What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

4K p`25C1/2 Joqqo =2j0z[32j f?LZ}fMuZ (ZZg; 4QSMQ|}|y^ L$ AhhZ=? Vl?VLUx7*r e4[EGze4w 5[w[53 t(%SF eui nK(d (! fDD\b7P^5;iH? eemAcrf8cer%. w3 KF~WIG$a -Sm ezeDM4ZEMz44 YV Z\\o^E :6n:g_s_vh _Yt_i_~,sC n:=f W0N ~2o;go@`H 3` QwCovQ4C q/[}[NVE*/ ghh4 =Izj Q085y| YI{^I :5Og;x%O: IHx i%6,K{\%6 3D_IOe- +TT,Vj 1( (zjF_1-,_z1 \b=#wrB=~ &*ny rV5* e6` tq/qt HC$HbHum~G 9u =K,, *J ft) deNe\*DWd Ry Z+Zgn: yX A_b_A.

jjDT+H0

_guM]\Wu o^XX^

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión